Digital Genome Market PowerPoint PPT Presentations

Genomics is a traditional concept with traces of genome market traced back right from 1926 when a geneticist at the Jackson Laboratory Tom Roderick, coined the term genomics. In 1981, the 1st complete genome sequence of the human mitochondrion (16.6 kb), was registered. Then in 2003 the accomplishment of the Human Genome Project, sequencing of 3.2 billion base pairs of a DNA that make up the human genome, which took many years and cost hefty amounts of time and capital was completely sequenced, with every single human gene sequences were accessible in the public domain.

Digital genome is the complete digital set of genes or genetic material present in a cell or organism.

Get more details @ http://bit.ly/2poGpMf Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.

Global digital genome market is estimated to grow at a CAGR of 9.57% during the forecasting years 2021-2028. Get Free Sample Report.

Global Digital Genome Market Information by Disease (cancer, diabetes), by End users hospitals, research laboratories) by application (diagnostics, drug discovery, academic research) - Forecast to 2027

Market Industry Reports (MIR) has published a new report titled “Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period. The growth of this market can be attributed to the major factor that is utilization of the technique for therapeutic genetic editing in infected tissues and cells, thereby reducing the mutations.

Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.

Goldstein Research analyst forecast the digital genome market size is set to reach USD 24.3 billion by 2025, at a CAGR of 8.78% over the forecast years

Get more details @ http://bit.ly/2nUpHlT Some of the key companies providing products and services in the digital genome market are Thermo Fisher, Perkin Elmer, Qiagen, Illumina, Becton Dickinson. Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, F. Hoffmann-La Roche, Agios, AVEO Oncology and Biomarin, BioReference.

The global digital biomanufacturing market report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.

Single User License: US $2500; Buy the Report @ http://www.sandlerresearch.org/purchase?rname=44172 Alternatively can get Discount on the Report @ http://www.sandlerresearch.org/discount?rname=44172

According to the latest research report by IMARC Group, The United States digital PCR market size reached US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 22.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-digital-pcr-market

According to the latest research report by IMARC Group, The global digital PCR market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 9.25% during 2024-2032. More Info:- https://www.imarcgroup.com/digital-pcr-market

Market Overview: Cancer Tissue Diagnostics Market Cancer tissue diagnostics play a pivotal role in oncology by facilitating accurate diagnosis, prognosis, and treatment selection based on tissue samples obtained from patients. The global cancer tissue diagnostics market is witnessing steady growth, driven by the increasing incidence of cancer, advancements in diagnostic technologies, and growing emphasis on personalized medicine.

[316 Pages Report] The Digital PCR market size is projected to reach $7.6 billion by 2025, at a CAGR of 9.0% between 2020 and 2025.

In 2017, the global Digital Health market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was estimated at $4876 million in 2020, and is projected to grow at a CAGR of 9.2% during the forecast period 2021-2026.

On the basis of type of application, the global digital PCR and qPCR market is classified into research applications, clinical applications, and forensic applications

Driving Toward the Digital Economy and Digital Manufacturing

Get Sample Brochure of Report @ http://www.marketintelreports.com/pdfdownload.php?id=9dime5731 The report includes detailed analysis on Digital PCR Devices market segmentation, global notable vendors, geographical outlook, price & financial updates, segment & application approach and future forecasts.

The global qPCR and dPCR market is expected to reach USD 4.94 Billion by 2021 from USD 3.28 Billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021.

Digital health is the convergence of digital and genomic technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by patients

This report studies the global digital PCR (dPCR) and qPCR market over the forecast period of 2014 to 2019. The market is expected to reach $3.97 billion by 2019, at CAGR of 7.8% from 2014 to 2019.

Global single-cell analysis market is set to witness a healthy CAGR of 17.5% in the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. This rise in the market can be attributed due to increasing adoption of single-cell analysis for diagnostic.

The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.

The spatial genomics and transcriptomics market was estimated at $269.6 Million in 2020 and is expected to grow at a CAGR of 23.20% during the forecast period from 2020-2030.

The global digital biomanufacturing market is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.

The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.

Market Report Titled "Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023" is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally .

The Market Report “Global Assisted Reproductive Technology Market 2018” Offers Vital Insights on every Industry segment in terms of market size analysis for Industry across the different regions.

The global cancer diagnostics market size was USD 175.1 billion in 2021 and is projected to grow at a CAGR of 7.2% to reach USD 305.3 billion by 2030. The Cancer Diagnostics Market is a rapidly evolving sector at the forefront of the global healthcare industry. Advancements in technology and increasing cancer prevalence drive market growth. Diagnostic methods like imaging, genomics

"AI in Social Media market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for AI in Social Media market.

Vaginitis is an inflammation of the vaginal tissues, often caused by infections or irritants. Treatment drugs for vaginitis typically include antibiotics, antifungals, and hormone therapies, aimed at addressing the underlying causes and alleviating symptoms. The global vaginitis treatment drug market is experiencing notable growth due to the increasing prevalence of vaginitis, heightened awareness, and advances in pharmaceutical formulations. According to Persistence Market Research's projections, the global vaginitis treatment drugs market is estimated to value at US$5.3 Bn by the end of 2031 from US$3.3 Bn estimated in 2024. The market is expected to secure a CAGR of 5.0% in the forthcoming years from 2024 to 2031.

The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/

"Content Services Platforms market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for Content Services Platforms market.

"Telecom System Integration market" In the genomics industry, highlighting higher level geographies and breaking down significant business sectors allows for in-depth study of market data. The study strikes the ideal balance between qualitative and quantitative data about the global market for Telecom System Integration market.

The global human microbiome market size reached US$ 817.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,586.3 Million by 2032, exhibiting a growth rate (CAGR) of 17.3% during 2024-2032.

The global cotton yarn market size reached US$ 75.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.87% during 2024-2032.

The Global Liquid Biopsy Market is expected to register 28.0% CAGR and is projected to reach USD 17,372.28 million by 2022.

The Global Multi-Omics Market which largely consists of Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness double digit growth.

The global pharmaceutical market is valued at approximately $1.2 trillion. Projections indicate sustained growth, with estimates anticipating a market value exceeding $1.5 trillion by 2025. The pharmaceutical market growth rate underscores its resilience and pivotal role in global healthcare.

A newly published report by Market Statsville Group (MSG), title dGlobal Pharmacogenomics Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Pharmacogenomics market will showcase an impressive CAGR from 2024 to 2033. The comprehensive Pharmacogenomics market research study highlights market dynamics, value chain analysis, regulatory framework, growing investment hotspots, competitive landscape, geographical landscape, and extensive market segments.

The global multiplex assays market is expected to register a CAGR of 8.12% during 2024-2032 and reach a revenue of $7793.26 million by 2032. Get more insights

Driving Toward Digital Prosperity

DNA Methylation Sequencing Market

A novel report on global Synthetic DNA Market is published by Emergen Research, offering current developments and emerging trends of the market.

The global artificial intelligence (AI) in epidemiology market is set to grow with a 27.33% CAGR between 2024 and 2032. Get more insights into our latest blogs

A newly published report by Market Statsville Group (MSG), titled Global Energy Management Systems Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Energy Management Systems market will showcase an impressive CAGR from 2024 to 2033.

The AI in Healthcare Market is projected to grow from USD 14.6 Billion in 2023 to USD 102.7 Billion by 2028; it is expected to grow at a CAGR of 47.6%

The AI in Healthcare Market is projected to grow from USD 14.6 Billion in 2023 to USD 102.7 Billion by 2028; it is expected to grow at a CAGR of 47.6%

Genotyping Market

The AI in Healthcare Market is projected to grow from USD 14.6 Billion in 2023 to USD 102.7 Billion by 2028; it is expected to grow at a CAGR of 47.6%

Lab Automation Market

A newly published report by Market Statsville Group (MSG), titled Global Prime Editing and CRISPR Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Prime Editing and CRISPR market will showcase an impressive CAGR from 2024 to 2033.

This has fueled the significant growth of the nutritional and dietary supplements market, estimated at a colossal $137.5 billion in 2023, and projected to reach a staggering $227.3 billion by 2030, with a robust CAGR of 7.6%.

The growing incidences of new infectious and chronic diseases and the escalating need for diagnostic procedures that accurately identify pathogens are primarily driving the biobanking market. Moreover, the increasing demand for regenerative medicines and personalized treatment options is further propelling the market growth.